Vtgn stock forecast.

Find the latest Aadi Bioscience, Inc. (AADI) stock quote, history, news and other vital information to help you with your stock trading and investing.6 brokers have issued 1 year price objectives for Olema Pharmaceuticals' shares. Their OLMA share price targets range from $18.00 to $28.00. On average, they predict the company's stock price to reach $21.20 in the next year. This suggests a possible upside of 45.4% from the stock's current price.For VistaGen Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average VistaGen Therapeutics stock forecast of $4.98, a high forecast of $6.23, and a low forecast of $3.42. The average VistaGen Therapeutics stock forecast 2031 represents a 44.91% increase from the last price of $3.44000005722046. Stock analysis for Vistagen Therapeutics Inc (VTGN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.১১ নভে, ২০২১ ... People flocked to the company's platform for online medical visits, and revenue, patient visits, and the share price soared. TDOC Chart. TDOC ...

VistaGen Therapeutics Stock Forecast and Price Target. The average target price set lately by experts for VistaGen Therapeutics to reach by the end of the year is $8.50, which would imply a potential upside of approximately 156.02 percent from the previous closing price if it were to be achieved.

Aug 29, 2023 · Vistagen Therapeutics Inc ( VTGN) is up 0.39% today. VTGN has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on VTGN! See Full VTGN Report. VTGN stock closed at $5.12 and is up $0.02 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only ...

74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Vistagen Therapeutics, Inc. (VTGN) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 3.6500 +0.0600 (+1.67%) At... Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...BIVI | Complete BioVie Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.fink. 10/14/23 1:04 PM. Post #4,990. Re: #4,989: @The_Q - A buddy told me this stock is $50-70. They have an impressive pipeline. But it's a pharma play. A time suck. They are in phase 3 for their first drug. Once they get those results they will submit to the FDA for approval.

We would like to show you a description here but the site won’t allow us.

For VistaGen Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average VistaGen Therapeutics stock forecast of $4.98, a high forecast of $6.23, and a low forecast of $3.42. The average VistaGen Therapeutics stock forecast 2031 represents a 44.91% increase from the last price of $3.44000005722046.

Jul 6, 2023 · Analyst Price Forecast Suggests 53.10% Downside As of July 6, 2023, the average one-year price target for VistaGen Therapeutics is 6.12. The forecasts range from a low of 6.06 to a high of $6.30. Nov 30, 2023 · Vistagen Therapeutics Stock Price, News & Analysis (NASDAQ:VTGN) $3.65 +0.06 (+1.67%) (As of 12/1/2023 ET) Compare Today's Range $3.47 $3.68 50-Day Range $2.57 $5.36 52-Week Range $1.62 $24.71 Volume 224,227 shs Average Volume 572,470 shs Market Capitalization $98.62 million P/E Ratio N/A Dividend Yield N/A Price Target $21.00 Find real-time MCOM - micromobility.com inc stock quotes, company profile, news and forecasts from CNN Business. Future criteria checks 2/6. Vistagen Therapeutics's earnings are forecast to decline at 12.9% per annum while its annual revenue is expected to grow at 80.5% per year. EPS is expected to grow by 30.5% per annum.See the latest Vistagen Therapeutics Inc stock price (VTGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Find the latest Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock quote, history, news and other vital information to help you with your stock trading and investing.Latest Vistagen Therapeutics Inc (VTGN:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.২ অক্টো, ২০২৩ ... (“Vistagen”) (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company ... At a combined purchase price of $5.38 per share of common stock ...Vistagen Therapeutics, Inc. (VTGN) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 3.6500 +0.0600 (+1.67%) At close: 04:00PM EST 3.6700 +0.02 (+0.55%) After hours: 07:55PM...

VTGN Earnings Forecast. Next quarter’s earnings estimate for VTGN is -$0.68 with a range of -$0.68 to -$0.68. The previous quarter’s EPS was -$0.94. VTGN beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.55% of the time in the same period.33. Shawn Singh. https://www.vistagen.com. Vistagen Therapeutics, Inc., a late clinical-stage biopharmaceutical company, primarily focus to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders. The company’s pipeline includes six clinical stage product candidates ...

In addition, VistaGen has granted the underwriter a 45-day option to purchase up to an additional 2,343,750 shares of common stock at the per share public offering price, less discounts and ...The 2 analysts offering 1 year price forecasts for VTGN have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to VTGN in the past 3 months. Oct 15, 2020 · VistaGen Therapeutics (VTGN) stock price prediction is 4.1549132874741 USD. The VistaGen Therapeutics stock forecast is 4.1549132874741 USD for 2024 November 29, Friday; and 6.863 USD for 2028 November 29, Wednesday with technical analysis. We would like to show you a description here but the site won’t allow us.What is VTGN's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors. This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors. VTGN Price Action: VistaGen shares surged on above average volume Monday. The stock was trending across social platforms most of the day and closed Monday's session up 676.8% at $13.05.Stock Information Stock Quote & Chart; Historical Data; Analyst Coverage; Press Releases; Events; SEC Filings All SEC Filings; Annual Reports; Quarterly Results; Section 16 Filings; Corporate Governance ... Investors Company Profile. Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the …

About the VistaGen Therapeutics, Inc. stock forecast. As of 2023 November 29, Wednesday current price of VTGN stock is 3.600$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).

Dec 1, 2023 · Vistagen Therapeutics, Inc is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Vistagen Therapeutics, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vistagen Therapeutics, Inc or its management.

Overview News Ideas Financials Technicals Forecast VTGN chart Today 7.16% 5 days 8.13% 1 month 20.07% 6 months −11.84% Year to date 11.62% 1 year −16.17% 5 years −92.84% All time −99.76% Key stats Market capitalization 97.013M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −4.71 USD Net income −59.248M USD Revenue In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.The average First Wave Biopharma stock price prediction forecasts a potential upside of 4,066.67% from the current FWBI share price of $0.25. What is FWBI's forecast return on equity (ROE) for 2023-2026? (NASDAQ: FWBI) forecast ROE is N/A, which is considered weak.The current Vistagen Therapeutics [ VTGN] share price is $3.38. The Score for VTGN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal. VTGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels. The Amesite Inc. stock price fell by -0.518% on the last day (Wednesday, 29th Nov 2023) from $1.93 to $1.92. During the last trading day the stock fluctuated 5.73% from a day low at $1.92 to a day high of $2.03. The price has fallen in 8 of the last 10 days and is down by -9.22% for this period. Volume fell on the last day along with the stock ...33. Shawn Singh. https://www.vistagen.com. Vistagen Therapeutics, Inc., a late clinical-stage biopharmaceutical company, primarily focus to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders. The company’s pipeline includes six clinical stage product candidates ...Based on short-term price targets offered by two analysts, the average price target for VistaGen Therapeutics, Inc. comes to $12.00. The forecasts range from a low of $12.00 to a high of $12.00 ...For comparison, the stock’s daily average trading volume is about 1.2 million shares. VTGN is down 85.3% as of Friday afternoon. There’s more recent stock market news to check out below!VTGN Stock Shows Promising Signs for Investors with Potential for Significant Growth VTGN stock performances on November 7, 2023, showed promising signs for investors. According to data from CNN Money, the 12-month price forecasts for Vistagen Therapeutics Inc had a median target of $12.00, with both the high and low …Get Vistagen Therapeutics Inc (VTGN.C) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Overview News Ideas Financials Technicals Forecast VTGN chart Today 0.00% 5 days 8.85% 1 month 20.20% 6 months −12.98% Year to date 14.73% 1 year −18.08% 5 years −93.29% All time −99.75% Key stats …2 brokers have issued 1-year target prices for Vistagen Therapeutics' stock. Their VTGN share price targets range from $12.00 to $30.00. On average, they predict the company's share price to reach $21.00 in the next year. This suggests a possible upside of 475.3% from the stock's current price.

Nov 30, 2023 · View VistaGen Therapeutics, Inc VTGN investment & stock information. Get the latest VistaGen Therapeutics, Inc VTGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Nov 30, 2023 · View VistaGen Therapeutics, Inc VTGN investment & stock information. Get the latest VistaGen Therapeutics, Inc VTGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Nov 27, 2023 · VTGN has an Altman Z-Score of -5.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for VistaGen Therapeutics, Inc. (VTGN) stock, including valuation metrics, financial numbers, share information and more. VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Number of Hedge Fund Holders: 15 Price as of August 1, 2021: $2.66 VistaGen Therapeutics, Inc. (NASDAQ: VTGN) stock has returned 186% to investors over ...Instagram:https://instagram. how to start day trading with no moneytrading free demoinvestment consulting firmwhat is amat Passion and purpose to transform patient journeys in anxiety and depression. VistaGen Therapeutics' is developing an innovative pipeline of Central Nervous System medications with the potential to establish new standards of care, safety, and effectiveness in the treatment of a variety of serious anxiety, depression and other CNS disorders.Vistagen Therapeutics Inc Follow Share $3.59 After Hours: $3.53 (1.67%) -0.060 Closed: Nov 24, 4:06:08 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to T2 Biosystems Inc $4.09 TTOO3.81% MEI... fastest growing stocks todaystock price alert app Their MBRX share price targets range from $5.00 to $16.00. On average, they predict the company's stock price to reach $10.50 in the next twelve months. This suggests a possible upside of 1,726.1% from the stock's current price. View analysts price targets for MBRX or view top-rated stocks among Wall Street analysts. us forex brokers that trade gold Future criteria checks 2/6. Vistagen Therapeutics's earnings are forecast to decline at 12.9% per annum while its annual revenue is expected to grow at 80.5% per year. EPS is expected to grow by 30.5% per annum.Fiscal Q2 2024 ended 9/30/23. Reported on 11/9/23. Get the latest Vistagen Therapeutics Inc (VTGN) real-time quote, historical performance, charts, and other financial information to help you...Vistagen Therapeutics (VTGN) Stock Forecast and Price Target 2023. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow.